A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia
- 16 March 2008
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 40 (4), 387-389
- https://doi.org/10.1038/ng.103
Abstract
We report the first identified mutation in the gene encoding human cytochrome c (CYCS). Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation. The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro. Notably, the family has no other phenotypic indication of abnormal apoptosis, implying that cytochrome c activity is not a critical regulator of most physiological apoptosis.Keywords
This publication has 16 references indexed in Scilit:
- Programmed Anuclear Cell Death Delimits Platelet Life SpanCell, 2007
- Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartmentBlood, 2006
- The mitochondrial death squad: hardened killers or innocent bystanders?Current Opinion in Cell Biology, 2005
- Specific Ablation of the Apoptotic Functions of Cytochrome c Reveals a Differential Requirement for Cytochrome c and Apaf-1 in ApoptosisCell, 2005
- Cytochrome C-Mediated ApoptosisAnnual Review of Biochemistry, 2004
- Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopeniaBritish Journal of Haematology, 2004
- MitochondriopathiesEuropean Journal of Neurology, 2004
- Stability and apoptotic activity of recombinant human cytochrome cBiochemical and Biophysical Research Communications, 2003
- Platelet formation is the consequence of caspase activation within megakaryocytesBlood, 2002
- A Mutational Epitope for Cytochrome c Binding to the Apoptosis Protease Activation Factor-1Journal of Biological Chemistry, 2001